Rehospitalization for respiratory syncytial virus among premature infants

Pediatrics

Volumn 104, Issue 4 I, 1999, Pages 894-899

  Joffe, Steven ^a,c   Escobar, Gabriel J ^a,b   Black, Steven B ^a,b   Armstrong, Mary Anne ^a   Lieu, Tracy A ^a,d  

^a DIVISION OF RESEARCH   (United States)

^b KAISER PERMANENTE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d HARVARD PILGRIM HEALTH CARE   (United States)

Author keywords

Bronchiolitis; Bronchopulmonary dysplasia; Chronic lung disease; Epidemiology; Infections; Intensive care; Neonatal; Neonatal infections; Passive immunization; Prematurity; Prophylaxis; Respiratory; Respiratory syncytial virus infections; Seasonal variation

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; INCIDENCE; INFANT; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK FACTOR;

CALIFORNIA; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; OXYGEN INHALATION THERAPY; PATIENT READMISSION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEASONS; SEVERITY OF ILLNESS INDEX;

EID: 0032853323     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.104.4.894     Document Type: Article

References (24)

1. Holberg CJ, Wright AL, Martinez FD, et al. Risk factors for respiratory syncytial virus-associated lower respiratory illness in the first year of life. Am J Epidemiol. 1991;133:1135-1151
2. Groothuis JR, Gutierrez KM, Lauer BA. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics. 1988; 82:199-203
3. Groothuis JR, Simoes EAF, Hemming VG, et al. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Pediatrics. 1995;95:463-467
4. Cunningham CK, McMillan JA, Gross SJ. Rehospitalization for respiratory illness in infants of less than 32 weeks' gestation. Pediatrics. 1991; 88:527-532
5. Law BJ, De Carvalho V, and the Pediatric Investigators Collaborative Network on Infections in Canada. Respiratory syncytial virus infections in hospitalized Canadian children: regional differences in patient populations and management practices. Pediatr Infect Dis J. 1993;12:659-663
6. Meert K, Heidemann S, Lieh-Lai M, et al. Clinical characteristics of respiratory syncytial virus infections in healthy versus previously compromised host. Pediatr Pulmonol. 1989;7:167-170
7. Navas L, Wang E, de Carvalho V, et al. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. J Pediatr. 1992;121:348-354
8. The PREVENT Study Group. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics. 1997;99:93-99
9. Wang EEL, Law BJ, Stephens D, et al. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1995;126: 212-219
10. Wang EEL, Law BJ, Robinson JL, et al. PICNIC (Pediatric Investigators Collaborative Network on Infections in Canada) study of the role of age and respiratory syncytial virus neutralizing antibody on respiratory syncytial virus illness in patients with underlying heart or lung disease. Pediatrics. 1997;99(3). URL: http://www.pediatrics.org/cgi/content/ full/99/3/e9
11. Nachman S, Navaie-Waliser M, Qureshi M. Rehospitalization with respiratory syncytial virus after neonatal intensive care unit discharge: a 3-year follow-up. Pediatrics. 1997;100(6). URL: http://www.pediatrics.org/cgi/ content/full/100/6/e8
12. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998; 102:531-537
13. American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IVIG. Pediatrics. 1998;102:1211-1216
14. American Academy of Pediatrics, Committee on Infectious Diseases, Committee on Fetus and Newborn. Respiratory syncytial virus immune globulin intravenous. Indications for use. Pediatrics. 1997;99:645-650
15. Storch GA. Humanized monoclonal antibody for prevention of respiratory syncytial virus infection. Pediatrics. 1998;102:648-650
16. Escobar G, Fischer A, Kremers R, et al. Rapid retrieval of neonatal outcomes data: the Kaiser Permanente neonatal minimum data set. Qual Management Health Care. 1997;5:19-33
17. Freeman RK, Poland RL, eds. Guidelines for Perinatal Care. 3rd ed. Elk Grove Village, IL: American Academy of Pediatrics and American College of Obstetricians and Gynecologists; 1992
18. International Classification of Diseases, 9th Revision, Clinical Modification. 5th ed. New York, NY: McGraw-Hill, Inc; 1996
19. O'Brodovich HM, Mellins RB. Bronchopulmonary dysplasia. Am Rev Respir Dis. 1985;132:694-709
20. US Bureau of the Census. Statistical Abstract of the United States: 1995. 115th ed. Washington, DC: US Government Printing Office; 1995
21. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82:703-710
22. Tison DL, Blixt D, Jouglard J, Performance of a commercial fluorescent antibody conjugate for the direct identification of respiratory syncytial virus from nasopharyngeal secretions. Abstracts of the Annual Meeting of the American Society of Microbiology. 1987;C52
23. Halstead DC, Todd S, Fritch G. Evaluation of five methods for respiratory syncytial virus detection. J Clin Microbiol. 1990;28:1021-1025
24. Gilchrist S, Torok TJ, Gary HE, Alexander JP, Anderson LJ. National surveillance for respiratory syncytial virus, United States 1985-1990. J Infect Dis. 1994;170:986-990